For the Inventor, By the Inventor

Enter assignee name

Fajardo, PR, United States of America

Warner Chilcott Company, LLC

USPTO Granted Patents = 39

% Expired Patents = 25.6

CIPO Patents = 39

EPO Patents = 15

Trademarks = 14

Forward Citations = 531

Loading Chart...

Loading Chart...

65 inventors (with patents filed for the assignee):

Roger M Boissonneault (6 out of 11 patents)

Tina deVries (5 out of 8 patents)

Richard John Dansereau (4 out of 22 patents)

4. David Ernest Burgio, Jr (4 out of 6 patents)

5. Gregory Paul Dittmar (3 out of 4 patents)

6. Frank Hallock Ebetino (3 out of 40 patents)

7. Roy Lee Martin Dobson (3 out of 3 patents)

8. Oluwole T Aloba (3 out of 3 patents)

9. John Alexander King (3 out of 3 patents)

10. James Keown (3 out of 3 patents)

11. James William McIlroy (3 out of 3 patents)

12. William Paul Armstrong (3 out of 3 patents)

13. Adam W Mazur (3 out of 21 patents)

14. Artem G Evdokimov (2 out of 58 patents)

15. Richard Masaru Kawamoto (2 out of 18 patents)

Core Competencies:

Pharmaceutical Dosage Forms

Graduated Estrogen Contraceptive

Bisphosphonate Compounds

Drug Delivery Devices

Prolyl Hydroxylase Inhibitors

Antimicrobial Quinolones

Vitamin D Uniformity

Oral Contraceptive Methods

Doxycycline Complexes

Human Protein Tyrosine Phosphatase

Extended Cycle Regimens

Compositions for Arrhythmia

39 patents: Sort by Forward Citations

1. 9255068 - Crystalline salts of (4S,4AS,5AR,12AS)-4-dimethylamino-3,10,12,12A-tetrahydroxy-7-[methoxy(methyl)amino)-methyl] acid amide and methods of using the same (2016-02-09),

2. 9132137 - Graduated estrogen contraceptive (2015-09-15),

3. 9089492 - Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures (2015-07-28),

4. 9035052 - Compositions of azimilide dihydrochloride (2015-05-19),

5. 8962010 - Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs (2015-02-24),

6. 8822435 - Bisphosphonate compounds (2014-09-02),

7. 8748476 - Darifenacin for use in the treatment of urgency induced by overactive bladder (2014-06-10),

8. 8710215 - Bisphosphonate compounds (2014-04-29),

9. 8703187 - Vitamin D content uniformity in pharmaceutical dosage forms (2014-04-22),

10. 8580302 - Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures (2013-11-12),

11. 8535718 - Dosage forms of bisphosphonates (2013-09-17),

12. 8461138 - Quadraphasis continuous graduated estrogen contraceptive (2013-06-11),

13. 8415331 - Doxycycline metal complex in a solid dosage form (2013-04-09),

14. 8409615 - Low dosage forms of risedronate or its salts (2013-04-02),

15. 8409614 - Low dosage forms of risedronate or its salts (2013-04-02),

Company Overview

Warner Chilcott Company, LLC is a pharmaceutical company based in Fajardo, Puerto Rico, specializing in the development and manufacturing of branded prescription medications. The company focuses on therapeutic areas such as women's health, dermatology, and urology, aiming to provide innovative solutions that enhance patient care. With a commitment to quality and efficacy, Warner Chilcott leverages advanced research methodologies to address unmet medical needs, contributing to the broader healthcare landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

39 Patents

#1 in Fajardo, PR

#4 in Puerto Rico

#8,802 in US

#17,448 in the World

Fajardo, PR, United States of America

Warner Chilcott Company, LLC

Forward Citations = 531

65 inventors:

Roger M Boissonneault (6 out of 11 patents)

Tina deVries (5 out of 8 patents)

Richard John Dansereau (4 out of 22 patents)

4. David Ernest Burgio, Jr (4 out of 6 patents)

5. Gregory Paul Dittmar (3 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Warner Chilcott Company, LLC. Retrieved from https://idiyas.com/company/warner-chilcott-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…